Monday, October 1, 2018

Focal Therapeutics Acquired For $125M

Aliso Viejo-based Focal Therapeutics, a developer of implantable medical devices used by surgeons in lumpectomy procedures, which is backed by Orange County-based Okapi Ventures, along with Emergent Capital Partners, has been acquired by Hologic, in a deal worth $125M in cash. Hologic is based in Marlborough, Mass. According to Hologic, the deal will help strengthen its position in the market for break conserving surgery. Focal's medical devices are used to mark tumor excision sites, for monitoring and future treatment. Hologic said Focal had approximately $16M in revenues for the last 12 months. Focal's co-founder and Chief Medical Officer is Dr. Gail Lebovic.